{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Enalaprilat&page=2", "query": { "intervention": "Enalaprilat", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Enalaprilat&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T11:53:09.280Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01035255", "title": "This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure With Reduced Ejection Fraction" ], "interventions": [ { "name": "LCZ696 200 mg BID", "type": "DRUG" }, { "name": "Enalapril 10 mg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8442, "start_date": "2009-12", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2016-08-15", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 155, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 129 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01035255" }, { "nct_id": "NCT07547878", "title": "Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Kidney Disease", "Type 2 Diabetes" ], "interventions": [ { "name": "Finerenone", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Lotensin", "type": "DRUG" }, { "name": "Capoten", "type": "DRUG" }, { "name": "Enalapril", "type": "DRUG" }, { "name": "Monopril", "type": "DRUG" }, { "name": "Lisinopril", "type": "DRUG" }, { "name": "Univasc", "type": "DRUG" }, { "name": "Aceon", "type": "DRUG" }, { "name": "Accupril", "type": "DRUG" }, { "name": "Altace", "type": "DRUG" }, { "name": "Mavik", "type": "DRUG" }, { "name": "Edarbi", "type": "DRUG" }, { "name": "Atacand", "type": "DRUG" }, { "name": "Avapro", "type": "DRUG" }, { "name": "Cozaar", "type": "DRUG" }, { "name": "Benicar", "type": "DRUG" }, { "name": "Micardis", "type": "DRUG" }, { "name": "Diovan", "type": "DRUG" }, { "name": "Invokana", "type": "DRUG" }, { "name": "Farxiga", "type": "DRUG" }, { "name": "Jardiance", "type": "DRUG" }, { "name": "Ertugliflozin", "type": "DRUG" }, { "name": "Brenzavvy", "type": "DRUG" }, { "name": "Sotagliflozin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 64, "start_date": "2026-04-30", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 1, "location_summary": "Temple, Texas", "locations": [ { "city": "Temple", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07547878" }, { "nct_id": "NCT00001534", "title": "Long Term Effects of Enalapril and Losartan on Genetic Heart Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hypertrophic Cardiomyopathy", "Left Ventricular Hypertrophy", "Myocardial Ischemia" ], "interventions": [ { "name": "Losartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 112, "start_date": "1996-09", "completion_date": "2003-04", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001534" }, { "nct_id": "NCT02639637", "title": "Effect of DPP4 Inhibition on Vasoconstriction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Neuropeptide Y", "type": "DRUG" }, { "name": "Enalaprilat", "type": "DRUG" }, { "name": "Valsartan 160mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 18, "start_date": "2015-12", "completion_date": "2017-09", "has_results": true, "last_update_posted_date": "2018-08-27", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02639637" }, { "nct_id": "NCT06218199", "title": "Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Heart Failure, Congestive" ], "interventions": [ { "name": "Furosemide", "type": "DRUG" }, { "name": "Torsemide", "type": "DRUG" }, { "name": "Bumetanide", "type": "DRUG" }, { "name": "sacubitril/valsartan", "type": "DRUG" }, { "name": "Hydralazine", "type": "DRUG" }, { "name": "Isosorbide Dinitrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Heart Center Research, LLC", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 80, "start_date": "2021-07-08", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2024-01-29", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 1, "location_summary": "Huntsville, Alabama", "locations": [ { "city": "Huntsville", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT06218199" }, { "nct_id": "NCT02874794", "title": "Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Heart Failure and Reduced Ejection Fraction" ], "interventions": [ { "name": "LCZ696 (sacubitril/valsartan)", "type": "DRUG" }, { "name": "Enalapril", "type": "DRUG" }, { "name": "Placebo of Enalapril", "type": "DRUG" }, { "name": "Placebo of LCZ696", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 465, "start_date": "2016-08-17", "completion_date": "2019-01-26", "has_results": true, "last_update_posted_date": "2021-01-05", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 81, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Beverly Hills, California + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02874794" }, { "nct_id": "NCT01754909", "title": "Mitigation of Radiation Pneumonitis and Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lung Cancer", "Radiation Pneumonitis" ], "interventions": [ { "name": "Enalapril", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "35 Years to 85 Years" }, "enrollment_count": 50, "start_date": "2013-11-01", "completion_date": "2018-04-01", "has_results": true, "last_update_posted_date": "2019-10-08", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 3, "location_summary": "Baltimore, Maryland • Ann Arbor, Michigan • Milwaukee, Wisconsin", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01754909" }, { "nct_id": "NCT00113698", "title": "Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Defects, Congenital", "Heart Septal Defects, Ventricular", "Heart Failure, Congestive" ], "interventions": [ { "name": "Enalapril", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "ALL", "summary": "Up to 18 Years" }, "enrollment_count": 5, "start_date": "2004-12", "completion_date": "2006-01", "has_results": false, "last_update_posted_date": "2014-03-13", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 6, "location_summary": "Boston, Massachusetts • New York, New York • Durham, North Carolina + 3 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00113698" }, { "nct_id": "NCT01318564", "title": "Diabetic Treatment Adherence", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Endocrine System Diseases" ], "interventions": [ { "name": "Metformin", "type": "DRUG" }, { "name": "Questionnaires", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "2011-03", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2016-09-12", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01318564" }, { "nct_id": "NCT01151410", "title": "An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Aliskiren", "type": "DRUG" }, { "name": "Enalapril", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 208, "start_date": "2010-08", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2016-03-07", "last_synced_at": "2026-09-26T11:53:09.280Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Dalton", "state": "Georgia" }, { "city": "Lewiston", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT01151410" } ] }